Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
or

Enovis Corp (ENOV)

Enovis Corp (ENOV)
16.00 x 2 41.56 x 2
Pre-market by (Cboe BZX)
40.00 +0.92 (+2.35%) 03/24/25 [NYSE]
16.00 x 2 41.56 x 2
Pre-market 40.00 unch (unch) 19:00 ET
Quote Overview for Mon, Mar 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
39.39
Day High
40.49
Open 39.60
Previous Close 39.08 39.08
Volume 558,400 558,400
Avg Vol 1,122,055 1,122,055
Stochastic %K 86.21% 86.21%
Weighted Alpha -32.52 -32.52
5-Day Change +0.81 (+2.07%) +0.81 (+2.07%)
52-Week Range 35.14 - 62.79 35.14 - 62.79
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,278,520
  • Shares Outstanding, K 56,963
  • Annual Sales, $ 2,108 M
  • Annual Income, $ -825,490 K
  • EBIT $ 35 M
  • EBITDA $ 970 M
  • 60-Month Beta 2.05
  • Price/Sales 1.06
  • Price/Cash Flow 2.05
  • Price/Book 0.87

Options Overview Details

View History
  • Implied Volatility 47.99% ( +1.02%)
  • Historical Volatility 41.83%
  • IV Percentile 60%
  • IV Rank 57.15%
  • IV High 68.07% on 10/16/24
  • IV Low 21.22% on 05/16/24
  • Put/Call Vol Ratio 0.27
  • Today's Volume 14
  • Volume Avg (30-Day) 75
  • Put/Call OI Ratio 3.32
  • Today's Open Interest 4,570
  • Open Int (30-Day) 8,096

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.74
  • Number of Estimates 4
  • High Estimate 0.76
  • Low Estimate 0.73
  • Prior Year 0.50
  • Growth Rate Est. (year over year) +48.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
35.14 +13.83%
on 03/04/25
Period Open: 43.53
43.75 -8.57%
on 02/25/25
-3.53 (-8.11%)
since 02/24/25
3-Month
35.14 +13.83%
on 03/04/25
Period Open: 43.95
49.38 -19.00%
on 01/27/25
-3.95 (-8.99%)
since 12/24/24
52-Week
35.14 +13.83%
on 03/04/25
Period Open: 60.21
62.79 -36.30%
on 04/09/24
-20.21 (-33.57%)
since 03/22/24

Most Recent Stories

More News
3 Stocks Under $50 in the Doghouse

3 Stocks Under $50 in the Doghouse

ENOV : 40.00 (+2.35%)
WEN : 15.07 (-1.25%)
LXFR : 11.82 (+2.07%)
Medical Devices & Supplies - Specialty Stocks Q4 In Review: Globus Medical (NYSE:GMED) Vs Peers

Medical Devices & Supplies - Specialty Stocks Q4 In Review: Globus Medical (NYSE:GMED) Vs Peers

INSP : 171.00 (+3.69%)
ENOV : 40.00 (+2.35%)
GMED : 76.06 (+3.36%)
BLCO : 15.91 (+2.25%)
HAE : 64.45 (+0.70%)
Enovis to Participate in Upcoming Investor Conferences

ENOV : 40.00 (+2.35%)
Enovis Hits Another 52-Week Low. Here’s Why It’s a Contrarian Buy.

The orthopedic medical device company hit its 41st 52-week low. The stock looks unnecessarily beaten down, off 41% over the past 12 months and 62% from its all-time high in November 2021, making it a contrarian...

ENOV : 40.00 (+2.35%)
DHR : 212.80 (+0.68%)
A Look Back at Medical Devices & Supplies - Specialty Stocks’ Q3 Earnings: STAAR Surgical (NASDAQ:STAA) Vs The Rest Of The Pack

A Look Back at Medical Devices & Supplies - Specialty Stocks’ Q3 Earnings: STAAR Surgical (NASDAQ:STAA) Vs The Rest Of The Pack

INSP : 171.00 (+3.69%)
ENOV : 40.00 (+2.35%)
ITGR : 117.18 (+1.75%)
STAA : 17.77 (+0.28%)
HAE : 64.45 (+0.70%)
Enovis (NYSE:ENOV) Exceeds Q4 Expectations

Enovis (NYSE:ENOV) Exceeds Q4 Expectations

ENOV : 40.00 (+2.35%)
Enovis: Q4 Earnings Snapshot

Enovis: Q4 Earnings Snapshot

ENOV : 40.00 (+2.35%)
Enovis Announces Fourth Quarter and Full Year 2024 Results

ENOV : 40.00 (+2.35%)
Enovis Announces Planned CEO Succession Process

ENOV : 40.00 (+2.35%)
Enovis (ENOV) Q4 Earnings: What To Expect

Enovis (ENOV) Q4 Earnings: What To Expect

ENOV : 40.00 (+2.35%)
INSP : 171.00 (+3.69%)
GMED : 76.06 (+3.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE.

See More

Key Turning Points

3rd Resistance Point 41.63
2nd Resistance Point 41.06
1st Resistance Point 40.53
Last Price 40.00
1st Support Level 39.43
2nd Support Level 38.86
3rd Support Level 38.33

See More

52-Week High 62.79
Fibonacci 61.8% 52.23
Fibonacci 50% 48.97
Fibonacci 38.2% 45.70
Last Price 40.00
52-Week Low 35.14

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals